Investor Relations
Partnerships are integral to Harbour BioMed's strategy to build a fully integrated biopharmaceutical company.
Partnerships are integral to Harbour BioMed's strategy to build a fully integrated biopharmaceutical company.

12.740hkd
12.320hkd
11.960hkd
11.560hkd
179.865K
| Share | last | High | Low | (+/-) | % | Bid | Ask | Volume |
|---|---|---|---|---|---|---|---|---|
| Beigene(HKSE) | 188.80 | 188.90 | 183.00 | 6.40 | 3.51 | 187.40 | 188.90 | 6,400 |
| Beigene | 312.66 | 313.69 | 302.62 | 11.17 | 3.70 | 300.00 | 390.52 | 196,081 |
BeiGenne(HKSE) Open:72.30 | High:183.50 | Low:172.05 | spanClose:182.40

| Currency | HKD |
| Market | Hong Kong (HKD) |
| NASDAQ (USD) | |
| ISIN code (BeiGene (HKSE)) | KYG1146Y1017 |
| ISIN code (BeiGene) | US07725L1026 |
| Ticker code (BeiGene (HKSE)) | 6160 |
| Ticker code (BeiGene) | BGNE |
| Industry | Healthcare |
| Market Capitalization | 223,642,415,806 |
| Number of Shares (BeiGene (HKSE)) | 1,175,209,752 |
| Number of Shares (BeiGene) | 90,413,860 |
| Time | Last | Volume |
|---|---|---|
| 16:08:12 | 183.00 | 200 |
| 16:08:12 | 183.00 | 3,600 |
| 16:08:12 | 183.00 | 400 |
| 16:08:12 | 183.00 | 200 |
| 16:08:12 | 183.00 | 600 |
| 16:08:12 | 183.00 | 400 |
| 16:08:12 | 183.00 | 300 |
| 16:08:12 | 183.00 | 100 |
| 16:08:12 | 183.00 | 500 |
| 16:08:12 | 183.00 | 1,000 |
| Instrument | 1m change % | 3m change % | 52m change % | 5 years change % | 52w high & low |
|---|---|---|---|---|---|
| BeiGene (HKSE) | 31.02% | 58.59% | 162.59% | N/A |
H:186.00 L:72.00 |
| BeiGene | 25.26% | 59.49% | 152.39% | N/A |
H:313.69 L:118.52 |
Copyright © 2025 Harbour BioMed. All Rights Reserved
沪公网安备31011502401396号
沪ICP备19015946号-1
a>
